An intervention to improve the timing of vancomycin levels.

OBJECTIVES Blood samples for vancomycin levels are often drawn too early, leading to potential misinterpretation of results. However, only a few studies describe interventions to reduce mistimed vancomycin levels. METHODS We implemented an information technology (IT)-based intervention that provided educational instructions to nurses and determined the percentage of levels drawn too early for 27 months before (n = 6,291) and 14 months after (n = 3,608) the intervention. In addition, we conducted nurse interviews (n = 40) and dataset analysis to assess the root causes of mistimed levels. RESULTS The percentage of vancomycin timing errors decreased from 39% (2,438/6,291) to 32% (1,137/3,608), though in a time series analysis this decrease was not statistically significant (P = .64). Four common causes of mistimed levels were found: (1) unclear provider orders, (2) scheduling levels to be drawn with morning laboratory tests, (3) lack of communication between providers, and (4) failure to adjust the blood draw in relation to the previous dose. CONCLUSIONS A real-time, IT-based intervention that links the timing of levels with medication administration might have a more substantial impact.

[1]  D. Bates,et al.  What proportion of vancomycin trough levels are drawn too early?: frequency and impact on clinical actions. , 2012, American journal of clinical pathology.

[2]  M. Swartling,et al.  Short term impact of guidelines on vancomycin dosing and therapeutic drug monitoring , 2012, International Journal of Clinical Pharmacy.

[3]  C. Frei,et al.  Effects of therapeutic drug monitoring criteria in a computerized prescriber-order-entry system on the appropriateness of vancomycin level orders. , 2011, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

[4]  David W Bates,et al.  A computer-based intervention for improving the appropriateness of antiepileptic drug level monitoring. , 2003, American journal of clinical pathology.

[5]  D W Bates,et al.  Evaluating the appropriateness of digoxin level monitoring. , 1999, Archives of internal medicine.

[6]  D. Bates Improving the use of therapeutic drug monitoring. , 1998, Therapeutic drug monitoring.

[7]  D W Bates,et al.  Strategies for physician education in therapeutic drug monitoring. , 1998, Clinical chemistry.

[8]  D W Bates,et al.  Appropriateness of antiepileptic drug level monitoring. , 1995, JAMA.

[9]  M. Winter,et al.  Appropriateness of sampling times for therapeutic drug monitoring. , 1984, American journal of hospital pharmacy.